Advent Bioservices

Advent Bioservices is a Contract Development & Manufacturing Organisation (CDMO) that launched its operations in 2016 with a focus on cell therapy. The company is currently in the process of establishing a cutting-edge production facility near Sawston in Cambridgeshire to meet the increasing demand for contract manufacturing services in the UK. This strategic location offers excellent transport links, including proximity to Cambridge city centre, London Stansted airport, and the M11 motorway, ensuring logistical efficiency. The state-of-the-art facility is designed to facilitate GMP production, with plans for future expansion. It comprises GMP lab space, process development areas, in-house quality control testing, office space, and a multipurpose cryogenic storage unit. Notably, the entire facility will be supported by a comprehensive IT infrastructure, incorporating electronic Quality Management Systems (eQMS), electronic Batch Manufacturing Records (eBMR), and Laboratory Information Management Systems (LIMS), ensuring secure and paperless operations. Advent Bioservices aims to provide a range of services, including process development, validation, training, and technical support to its clients. Moreover, their cryogenic facilities offer off-site storage and disaster recovery services in compliance with UK regulatory requirements, particularly those of the Human Tissue Authority (HTA). The company operates in the Biotechnology, Life Sciences, and Manufacturing industries, positioning itself at the intersection of innovation and commercialization in these sectors. Although specific details about recent investments and headquarters are not available, Advent Bioservices’ focus on cutting-edge infrastructure and integrated services places it in a promising position within the rapidly evolving biotechnology and manufacturing landscape.